Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

With the emergence and long-term Impact of COVID-19, Global Mammalian Cell Fermentation Technology Market to reach USD 76.63 billion by 2030

Bizwit Research & Consulting LLP’s recent analysis on the Global Mammalian Cell Fermentation Technology Market points towards a potential rise to USD 76.63 billion by 2030. Mammalian cell fermentation is widely used to create a variety of biosimilars, enzymes, vaccines, and other biologics. It is an essential step in the development of biopharmaceuticals. Mammalian cells are cultured in a bioreactor for fermentation after being produced in vitro from stem cells. The essential byproducts are produced during this process by the cells using a variety of metabolic pathways. The market for Mammalian Cell Fermentation Technology is driven due to factors such as growing prevalence of chronic diseases, growing need for novel and secure therapies and the growing demand for biologics and biosimilars.

Geographically, the global Mammalian Cell Fermentation Technology market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 with the largest market share owing to the region’s strong biopharmaceutical industry presence, supportive government regulations, and well-developed healthcare infrastructure.

Additionally, the increased demand for biologics and biosimilars as well as the rising prevalence of chronic diseases have contributed to the expansion of the market in the region. Asia Pacific is expected to a fastest growing region during the forecast period, owing to factors such as a big patient population, increasing demand for biologic pharmaceuticals, government initiatives to support biotechnology research and development, and a growth in contract manufacturing organizations (CMOs) in the region, are driving this expansion.

The global Mammalian Cell Fermentation Technology market is highly competitive owing to the presence of several key manufacturers such as Thermo Fisher Scientific, Inc. Merck KGaA Danaher Corporation Lonza Group Hoffmann-La Roche Ltd Sartorius AG AstraZeneca Bristol-Myers Squibb Amgen Inc. Gilead Sciences Inc, and others.

For further analysis on this or to request a sample copy of this report, please click the link mentioned below:

Global Mammalian Cell Fermentation Technology Market Size Study & Forecast, by Type (Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Baby Hamster Kidney (BHK) Cell Fermentation, Murine Myeloma Cell Fermentation, Others), By Application (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes and Others), By End-use (Biopharmaceutical Companies, CMOs & CDMOs, Academic & Research Institutes) and Regional Analysis, 2023-2030

Key findings of the study suggest:

  • Global Mammalian Cell Fermentation Technology Market is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast period 2023-2030.
  • In Type segment, Hamster Ovary (CHO) Cell Fermentation emerged as the leading market segment in 2023.
  • North America is anticipated to drive regional growth owing to strong biopharmaceutical industry presence in the region.
  • Asia Pacific is also expected to grow at a higher rate during 2023-2030 owing to increasing demand for biologic pharmaceuticals in the region.

Bizwit Research & Consulting has considered following segments for the study:

By Type:

  • Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

By Application:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Others

By End Use:

  • Biopharmaceutical Companies
  • CMOs & CDMOs
  • Academic & Research Institutes

Regional Outlook

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Korea
    • Australia
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com

About Us

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporates big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.

Contact US

Global Business Development

Phone: +1 209 498-3066

Email: Sales@bizwitresearch.com

Website: www.bizwitresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *